Table 2.
Top 25 signature candidate analytes.
| Elimination rank | Name | Median elimination score | Wilcoxon p‐value | Benjamini–Hochberg q‐value | Wilcoxon rank | Previous elimination rank (Wingren et al., 2012) |
|---|---|---|---|---|---|---|
| 1 | Properdin | 1 | 6.18E‐15 | 2.08E‐12 | 1 | 3 |
| 2 | VEGF (3) | 2 | 1.84E‐08 | 3.10E‐06 | 2 | 17 |
| 3 | IL‐8 (3) | 11.5 | 1.99E‐03 | 6.07E‐02 | 11 | 114 |
| 4 | C3 (4) | 12.5 | 3.74E‐05 | 3.15E‐03 | 4 | N/A |
| 5 | CHP‐1 (2) | 13 | 4.47E‐06 | 5.00E‐04 | 3 | N/A |
| 6 | C3 (3) | 17 | 1.31E‐01 | 6.01E‐01 | 72 | N/A |
| 7 | MAPK‐8 (3) | 19.5 | 1.85E‐04 | 7.76E‐03 | 8 | N/A |
| 8 | MCP‐1 (6) | 19.5 | 1.32E‐01 | 6.01E‐01 | 74 | N/A |
| 9 | IL‐7 (2) | 23 | 2.53E‐01 | 7.60E‐01 | 111 | 21 |
| 10 | C4 (3) | 23.5 | 2.96E‐03 | 8.29E‐02 | 12 | N/A |
| 11 | IgM (5) | 24.5 | 5.61E‐05 | 3.77E‐03 | 5 | N/A |
| 12 | IL‐3 (1) | 27 | 7.36E‐02 | 5.72E‐01 | 40 | 18 |
| 13 | IL‐11 (3) | 28 | 2.17E‐02 | 3.03E‐01 | 24 | 35 |
| 14 | C5 (2) | 31 | 1.81E‐02 | 2.84E‐01 | 21 | 1 |
| 15 | IL‐6 (6) | 32 | 4.95E‐01 | 8.88E‐01 | 187 | N/A |
| 16 | C3 (6) | 35 | 6.06E‐02 | 5.66E‐01 | 36 | N/A |
| 17 | ICAM‐1 | 37 | 7.36E‐01 | 9.37E‐01 | 263 | N/A |
| 18 | MCP‐1 (1) | 38.5 | 1.22E‐01 | 5.89E‐01 | 69 | 15 |
| 19 | LDL (1) | 39.5 | 2.33E‐01 | 7.52E‐01 | 104 | N/A |
| 20 | JAK3 | 42 | 1.96E‐02 | 2.86E‐01 | 23 | 34 |
| 21 | MAPK‐8 (2) | 43 | 6.79E‐02 | 5.72E‐01 | 38 | N/A |
| 22 | MUC‐1 (5) | 44.5 | 1.02E‐02 | 2.29E‐01 | 15 | 53 |
| 23 | BTK (3) | 44.5 | 2.06E‐01 | 7.26E‐01 | 93 | N/A |
| 24 | IL‐7 (1) | 45 | 1.61E‐01 | 6.61E‐01 | 82 | 88 |
| 25 | LUM | 46.5 | 1.04E‐01 | 5.89E‐01 | 55 | N/A |